Remarkably, KDM6A and KMD6B inhibition greatly decreased the expression of bulk and LGR5-refined ISC signatures (Figure 4E), which have been shown to be able to identify CSCs in CRC and predict CRC recurrence. This evidence concerns the gene LGR5 and colorectal carcinoma.